Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02442804 · ClinicalTrials.gov registry record · Phase 2
Cognitive Impact of Pomegranate Polyphenols Following Ischemic Stroke
A Phase 2 study, sponsored by Loma Linda University.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT02442804 is a Phase 2 study that has completed, run by Loma Linda University. The registered enrollment target is 16 participants.
The verdict
NCT02442804, a Phase 2 study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether pomegranate supplements improve cognitive functioning following stroke.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT POMx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02442804
The ClinicalTrials.gov registry entry for NCT02442804 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02442804 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02442804 about?
NCT02442804 is a clinical study titled "Cognitive Impact of Pomegranate Polyphenols Following Ischemic Stroke". The purpose of this study is to determine whether pomegranate supplements improve cognitive functioning following stroke.
What is the current status of trial NCT02442804?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2015-06. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02442804?
The interventions under investigation include: Placebo (OTHER), POMx (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02442804?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.